{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T15:15:40Z","timestamp":1778771740441,"version":"3.51.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018703","name":"European Innovation Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018694","name":"European Commission Marie Sklodowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018694","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bbagen.2026.130955","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:17:51Z","timestamp":1776467871000},"page":"130955","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting cancer cell sialylation with monosaccharide analogues modulates EGFR in colorectal cancer cells"],"prefix":"10.1016","volume":"1870","author":[{"given":"Jordan","family":"Gotti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"do Vale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrique O.","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana F.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"And\u00fajar-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Burock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erdmann","family":"Rapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joana","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catarina","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celso A.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2026.130955_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbagen.2026.130955_bb0010","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1136\/gutjnl-2025-335412","article-title":"Current and emerging concepts for systemic treatment of metastatic colorectal cancer","volume":"74","author":"Steup","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.bbagen.2026.130955_bb0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.annonc.2022.10.003","article-title":"Metastatic colorectal cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Cervantes","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbagen.2026.130955_bb0020","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1200\/JCO.22.01690","article-title":"Treatment of metastatic colorectal cancer: ASCO guideline","volume":"41","author":"Morris","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbagen.2026.130955_bb0025","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.cgh.2016.02.008","article-title":"Molecular biomarkers in the personalized treatment of colorectal cancer","volume":"14","author":"Sinicrope","year":"2016","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbagen.2026.130955_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70474","article-title":"Colorectal cancer molecular profiling: opportunities for early detection","volume":"15","author":"Sala","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbagen.2026.130955_bb0035","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.gendis.2019.10.013","article-title":"Molecular subtypes of colorectal cancer: an emerging therapeutic opportunity for personalized medicine","volume":"8","author":"Singh","year":"2021","journal-title":"Genes Diseas."},{"key":"10.1016\/j.bbagen.2026.130955_bb0040","first-page":"226","article-title":"Targeted therapy of cancer: new prospects for antibodies and immunoconjugates","volume":"56","author":"Sharkey","year":"2006","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbagen.2026.130955_bb0045","first-page":"372","article-title":"Clinical management of metastatic colorectal cancer in the era of precision medicine","volume":"72","author":"Ciardiello","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbagen.2026.130955_bb0050","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s42003-022-03884-x","article-title":"Genetic and microenvironmental intra-tumor heterogeneity impacts colorectal cancer evolution and metastatic development","volume":"5","author":"Sobral","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbagen.2026.130955_bb0055","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41575-022-00736-1","article-title":"Therapeutic landscape and future direction of metastatic colorectal cancer","volume":"20","author":"Bando","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbagen.2026.130955_bb0060","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.3390\/cancers13112748","article-title":"EGFR in cancer: signaling mechanisms, drugs, and acquired resistance","volume":"13","author":"Uribe","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbagen.2026.130955_bb0065","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/cancers16020412","article-title":"Cetuximab as a key partner in personalized targeted therapy for metastatic colorectal cancer","volume":"16","author":"Saoudi Gonz\u00e1lez","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bbagen.2026.130955_bb0070","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jamaoncol.2016.3797","article-title":"Prognostic and predictive relevance of primary tumor location in patients with RAS wild-type metastatic colorectal cancer: retrospective analyses of the CRYSTAL and FIRE-3 trials","volume":"3","author":"Tejpar","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.bbagen.2026.130955_bb0075","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/bjc.2017.93","article-title":"Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study","volume":"116","author":"Guren","year":"2017","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbagen.2026.130955_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.103916","article-title":"An empirical review on the resistance mechanisms of epidermal growth factor receptor inhibitors and predictive molecular biomarkers in colorectal cancer","volume":"183","author":"Bhattacharya","year":"2023","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.bbagen.2026.130955_bb0085","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.trecan.2022.02.003","article-title":"Insights on ErbB glycosylation \u2013 contributions to precision oncology","volume":"8","author":"Duarte","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bbagen.2026.130955_bb0090","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/glycob\/cww086","article-title":"Biological roles of glycans","volume":"27","author":"Varki","year":"2017","journal-title":"Glycobiology"},{"key":"10.1016\/j.bbagen.2026.130955_bb0095","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc3982","article-title":"Glycosylation in cancer: mechanisms and clinical implications","volume":"15","author":"Pinho","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbagen.2026.130955_bb0100","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ccell.2019.06.006","article-title":"Glycosylation in the era of cancer-targeted therapy: where are we heading?","volume":"36","author":"Mereiter","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbagen.2026.130955_bb0105","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/bs.acr.2014.11.004","article-title":"Glycosylation characteristics of colorectal cancer","volume":"126","author":"Holst","year":"2015","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.bbagen.2026.130955_bb0110","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2741\/e396","article-title":"Sialyltransferases functions in cancers","volume":"4","author":"Harduin-Lepers","year":"2012","journal-title":"Front. Biosci. (Elite Ed.)"},{"key":"10.1016\/j.bbagen.2026.130955_bb0115","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.biocel.2009.09.010","article-title":"Differential expression of alpha-2,3-sialyltransferases and alpha-1,3\/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells","volume":"42","author":"Carvalho","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bbagen.2026.130955_bb0120","first-page":"1443","article-title":"ST6GalNAc-I controls expression of sialyl-Tn antigen in gastrointestinal tissues","volume":"3","author":"Marcos","year":"2011","journal-title":"Front. Biosci. (Elite Ed.)"},{"key":"10.1016\/j.bbagen.2026.130955_bb0125","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s10719-023-10113-y","article-title":"ST3GalIV drives SLeX biosynthesis in gastrointestinal cancer cells and associates with cancer cell motility","volume":"40","author":"Costa","year":"2023","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.bbagen.2026.130955_bb0130","doi-asserted-by":"crossref","first-page":"21011","DOI":"10.1016\/S0021-9258(19)36790-0","article-title":"Primary structure of gal beta 1,3(4)GlcNAc alpha 2,3-sialyltransferase determined by mass spectrometry sequence analysis and molecular cloning. Evidence for a protein motif in the sialyltransferase gene family","volume":"267","author":"Wen","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2026.130955_bb0135","doi-asserted-by":"crossref","first-page":"17735","DOI":"10.1016\/S0021-9258(18)45441-5","article-title":"Primary structure of beta-galactoside alpha 2,6-sialyltransferase. Conversion of membrane-bound enzyme to soluble forms by cleavage of the NH2-terminal signal anchor","volume":"262","author":"Weinstein","year":"1987","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2026.130955_bb0140","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10719-023-10123-w","article-title":"The vertebrate sialylation machinery: structure-function and molecular evolution of GT-29 sialyltransferases","volume":"40","author":"Harduin-Lepers","year":"2023","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.bbagen.2026.130955_bb0145","first-page":"983","article-title":"ST6GAL1: a key player in cancer","volume":"18","author":"Garnham","year":"2019","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbagen.2026.130955_bb0150","doi-asserted-by":"crossref","first-page":"629","DOI":"10.5009\/gnl.2013.7.6.629","article-title":"Increasing the \u03b1 2, 6 sialylation of glycoproteins may contribute to metastatic spread and therapeutic resistance in colorectal cancer","volume":"7","author":"Park","year":"2013","journal-title":"Gut. Liver"},{"key":"10.1016\/j.bbagen.2026.130955_bb0155","doi-asserted-by":"crossref","first-page":"34627","DOI":"10.1074\/jbc.M114.593392","article-title":"\u0392-Galactoside \u03b12,6-sialyltranferase 1 promotes transforming growth factor-\u03b2-mediated epithelial-mesenchymal transition","volume":"289","author":"Lu","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2026.130955_bb0160","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.RA120.014126","article-title":"Glycosyltransferase ST6Gal-I promotes the epithelial to mesenchymal transition in pancreatic cancer cells","volume":"296","author":"Britain","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2026.130955_bb0165","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s13402-021-00606-z","article-title":"Terminal \u03b12,6-sialylation of epidermal growth factor receptor modulates antibody therapy response of colorectal cancer cells","volume":"44","author":"Rodrigues","year":"2021","journal-title":"Cell. Oncol. (Dordr)"},{"key":"10.1016\/j.bbagen.2026.130955_bb0170","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/molbev\/msu395","article-title":"Integrative view of \u03b12,3-sialyltransferases (ST3Gal) molecular and functional evolution in deuterostomes: significance of lineage-specific losses","volume":"32","author":"Petit","year":"2015","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.bbagen.2026.130955_bb0175","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/biology6010016","article-title":"Selectin ligands Sialyl-Lewis A and Sialyl-Lewis X in gastrointestinal cancers","volume":"6","author":"Trinchera","year":"2017","journal-title":"Biology"},{"key":"10.1016\/j.bbagen.2026.130955_bb0180","doi-asserted-by":"crossref","first-page":"7431","DOI":"10.7150\/thno.33858","article-title":"Carcinoembryonic antigen carrying SLe(X) as a new biomarker of more aggressive gastric carcinomas","volume":"9","author":"Gomes","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.bbagen.2026.130955_bb0185","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1021\/bi027101p","article-title":"Characterization of glycosylation sites of the epidermal growth factor receptor","volume":"42","author":"Zhen","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2026.130955_bb0190","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/oxfordjournals.jbchem.a022585","article-title":"Characterization of the n-oligosaccharides attached to the atypical Asn-X-Cys sequence of recombinant human epidermal growth factor receptor","volume":"127","author":"Sato","year":"2000","journal-title":"J. Biochem."},{"key":"10.1016\/j.bbagen.2026.130955_bb0195","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/glycob\/cwp023","article-title":"Knockdown of GnT-Va expression inhibits ligand-induced downregulation of the epidermal growth factor receptor and intracellular signaling by inhibiting receptor endocytosis","volume":"19","author":"Guo","year":"2009","journal-title":"Glycobiology"},{"key":"10.1016\/j.bbagen.2026.130955_bb0200","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1074\/jbc.R110.191429","article-title":"Emerging role of alpha2,6-sialic acid as a negative regulator of galectin binding and function","volume":"286","author":"Zhuo","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2026.130955_bb0205","doi-asserted-by":"crossref","first-page":"11956","DOI":"10.1074\/jbc.M008551200","article-title":"Overexpression of n-acetylglucosaminyltransferase III enhances the epidermal growth factor-induced phosphorylation of ERK in HeLaS3 cells by up-regulation of the internalization rate of the receptors","volume":"276","author":"Sato","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2026.130955_bb0210","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/glycob\/cwu051","article-title":"Overexpression of \u03b1 (1,6) fucosyltransferase associated with aggressive prostate cancer","volume":"24","author":"Wang","year":"2014","journal-title":"Glycobiology"},{"key":"10.1016\/j.bbagen.2026.130955_bb0215","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1042\/BST20200763","article-title":"Aberrant protein glycosylation in cancer: implications in targeted therapy","volume":"49","author":"Rodrigues","year":"2021","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.bbagen.2026.130955_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105217","article-title":"Sialylation of EGFR by ST6GAL1 induces receptor activation and modulates trafficking dynamics","volume":"299","author":"Ankenbauer","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2026.130955_bb0225","doi-asserted-by":"crossref","first-page":"1178817","DOI":"10.3389\/fimmu.2023.1178817","article-title":"Disruption of the sialic acid\/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cells","volume":"14","author":"Lustig","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbagen.2026.130955_bb0230","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41589-020-0622-x","article-title":"Targeted glycan degradation potentiates the anticancer immune response in vivo","volume":"16","author":"Gray","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbagen.2026.130955_bb0235","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.tibs.2016.03.007","article-title":"Sialic acid mimetics to target the sialic acid-Siglec axis","volume":"41","author":"B\u00fcll","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbagen.2026.130955_bb0240","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/17460441.2024.2444375","article-title":"Novel anticancer drug discovery efforts targeting glycosylation: the emergence of fluorinated monosaccharides analogs","volume":"20","author":"Costa","year":"2025","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bbagen.2026.130955_bb0245","doi-asserted-by":"crossref","first-page":"e925","DOI":"10.1002\/onco.13911","article-title":"First-in-human, first-in-class, phase I trial of the fucosylation inhibitor SGN-2FF in patients with advanced solid tumors","volume":"26","author":"Do","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.bbagen.2026.130955_bb0250","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1158\/1535-7163.MCT-13-0279","article-title":"Targeting aberrant sialylation in cancer cells using a fluorinated sialic acid analog impairs adhesion, migration, and in vivo tumor growth","volume":"12","author":"B\u00fcll","year":"2013","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbagen.2026.130955_bb0255","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nchembio.999","article-title":"Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome","volume":"8","author":"Rillahan","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bbagen.2026.130955_bb0260","doi-asserted-by":"crossref","first-page":"1800282","DOI":"10.1002\/pmic.201800282","article-title":"The fine art of destruction: a guide to in-depth glycoproteomic analyses\u2014exploiting the diagnostic potential of fragment ions","volume":"18","author":"Hoffmann","year":"2018","journal-title":"Proteomics"},{"key":"10.1016\/j.bbagen.2026.130955_bb0265","doi-asserted-by":"crossref","first-page":"1593708","DOI":"10.3389\/fmolb.2025.1593708","article-title":"Raider of the lost n-glycans \u2013 localizing rare and frequently overlooked IgG n-glycans with sulfation or bisecting LacNAc","volume":"12","author":"Burock","year":"2025","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.bbagen.2026.130955_bb0270","doi-asserted-by":"crossref","first-page":"cwae045","DOI":"10.1093\/glycob\/cwae045","volume":"34","author":"Arigoni-Affolter","year":"2024","journal-title":"Glycobiology"},{"key":"10.1016\/j.bbagen.2026.130955_bb0275","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.3390\/molecules28041843","article-title":"Reliable N-Glycan analysis\u2013removal of frequently occurring oligosaccharide impurities by enzymatic degradation","volume":"28","author":"Burock","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bbagen.2026.130955_bb0280","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1038\/onc.2008.19","article-title":"Mechanisms of acquired resistance to cetuximab: role of HER (ErbB) family members","volume":"27","author":"Wheeler","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bbagen.2026.130955_bb0285","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1200\/JCO.2009.24.6116","article-title":"Molecular mechanisms of resistance to cetuximab and panitumumab in colorectal cancer","volume":"28","author":"Bardelli","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbagen.2026.130955_bb0290","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s10719-012-9386-1","article-title":"Potential roles of n-glycosylation in cell adhesion","volume":"29","author":"Gu","year":"2012","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.bbagen.2026.130955_bb0295","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.bbrc.2017.03.167","article-title":"Differential expression of ST6GAL1 in the tumor progression of colorectal cancer","volume":"486","author":"Zhang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2026.130955_bb0300","doi-asserted-by":"crossref","first-page":"66491","DOI":"10.18632\/oncotarget.11582","article-title":"Metabolic flux-driven sialylation alters internalization, recycling, and drug sensitivity of the epidermal growth factor receptor (EGFR) in SW1990 pancreatic cancer cells","volume":"7","author":"Mathew","year":"2016","journal-title":"Oncotarget"}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416526000553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304416526000553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T15:02:00Z","timestamp":1778770920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304416526000553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":60,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0304416526000553"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2026.130955","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting cancer cell sialylation with monosaccharide analogues modulates EGFR in colorectal cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2026.130955","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"130955"}}